Stocks · Health care · Services-Medical Laboratories

BIODESIX INC

BDSX Clue Score48
United States Fiscal year ends December CIK 0001439725 Results filed 5 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Robin Harper Cowie
10 Nov 2025
CFO, Sec'y & Treasurer
Sold after exercise
50
$7.62
$381.00
Scott Hutton
10 Nov 2025
President & CEO
Sold after exercise
189
$7.62
$1.44K
Kieran O'Kane
10 Nov 2025
Chief Commercial Officer
Sold after exercise
25
$7.62
$190.50
Gary Anthony Pestano
10 Nov 2025
Chief Development Officer
Sold after exercise
23
$7.62
$175.26
Chris Vazquez
10 Nov 2025
Chief Accounting Officer
Sold after exercise
13
$7.62
$99.06

What was left out

Form 4 filings counted 38
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 5
Sales at will 15
Transactions with no price 0
Shares from compensation/vesting 37,235
History held since 3 Nov 2020